Vivos Therapeutics, Inc. ( VVOS) - Stock Earnings
VVOS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 18, 2026, midnight | — / — | — | — / — | — |
VVOS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -7.0 million USD | 3.8 million USD |
| 2026Q1 | -7.8 million USD | 5.1 million USD |
| 2026Q2 | -5.5 million USD | 5.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VVOS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.6 million USD | 13.8 million USD |
| 2024 | -11.1 million USD | 15.0 million USD |
| 2025 | -21.2 million USD | 17.4 million USD |
| 2026 Est. | — | — |
VVOS
Price: $0.11
52 week price:
Earnings Per Share: -1.88 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 77800
Market Capitalization: 2.1 million